Australia markets close in 5 hours 6 minutes

Knight Therapeutics Inc. (KHTRF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.2600+0.0700 (+1.67%)
At close: 12:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 423.68M
Enterprise value 350.31M
Trailing P/E N/A
Forward P/E 95.24
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.88
Price/book (mrq)0.78
Enterprise value/revenue 1.07
Enterprise value/EBITDA 8.57

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 321.10%
S&P500 52-week change 323.57%
52-week high 34.2900
52-week low 33.2010
50-day moving average 34.0468
200-day moving average 33.7611

Share statistics

Avg vol (3-month) 36.5k
Avg vol (10-day) 32.02k
Shares outstanding 5101.17M
Implied shares outstanding 6101.93M
Float 852.06M
% held by insiders 146.44%
% held by institutions 113.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -5.13%
Operating margin (ttm)-0.11%

Management effectiveness

Return on assets (ttm)0.40%
Return on equity (ttm)-2.14%

Income statement

Revenue (ttm)328.2M
Revenue per share (ttm)3.05
Quarterly revenue growth (yoy)-9.10%
Gross profit (ttm)N/A
EBITDA 53.26M
Net income avi to common (ttm)-16.84M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)169.87M
Total cash per share (mrq)1.68
Total debt (mrq)69.09M
Total debt/equity (mrq)9.25%
Current ratio (mrq)3.20
Book value per share (mrq)7.38

Cash flow statement

Operating cash flow (ttm)35.94M
Levered free cash flow (ttm)27.2M